 |
 |
 |
 |
 |
 |
 |
|
|||||||
|
CONTENT VALIDATION AND DISCLOSURES
Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the Research To Practice scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.
RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The following scientific staff and reviewers for Research To Practice reported real or apparent conflicts of interest for themselves (or their spouses/ partners), which have been resolved through a conflict of interest resolution process: Aviva Asnis-Alibozek, PA-C, MPAS — Salary: AstraZeneca Pharmaceuticals LP; Shareholder of: AstraZeneca Pharmaceuticals LP; Marie Bialek, PharmD — Freelancer/Contractor: McNeil Consumer & Specialty Pharmaceuticals; Sally Bogert, RNC, WHCNP — Shareholder of: Amgen Inc and Genentech BioOncology. All other Research To Practice staff and external reviewers: No real or apparent conflicts of interest to report.
FACULTY — The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Dr Bunn — Consulting Fees: Amgen Inc, AstraZeneca Pharmaceuticals LP, Biogen Idec, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Genentech BioOncology, GlaxoSmithKline, ImClone Systems, Novartis Pharmaceuticals Corporation, OSI Pharmaceuticals Inc, Roche Laboratories Inc, Sanofi-Aventis. Dr Hanna — Consulting Fees: Bayer Pharmaceuticals Corporation, Eli Lilly and Company; Contracted Research: Bristol-Myers Squibb Company, Eli Lilly and Company, Genentech BioOncology, Onyx Pharmaceuticals Inc. Dr Wozniak — Consulting Fees: AstraZeneca Pharmaceuticals LP, Sanofi-Aventis; Contracted Research and Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: Eli Lilly and Company, Genentech BioOncology.
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.
| Table of Contents | Top of Page |
EDITOR
Neil Love, MD
INTERVIEWS
Paul A Bunn Jr, MD
- Select publications
Nasser H Hanna, MD
- Select publications
Antoinette J Wozniak, MD
- Select publications
A CME Audio Series and Activity
 |
 |
 |
 |
 |
